← back to search

Craig Luccarini

University of Cambridge · GB
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Genetic Associations and Epidemiology, Genetic factors in colorectal cancer, and Nutrition, Genetics, and Disease.
h-index
39
citations
12,820
works
112
NIH funding
primary concept
email

Recent publications

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
Nature Communications 2025cited by 7position: middledoi
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
medRxiv 2024cited by 3position: middledoi
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
Nature Genetics 2023cited by 61position: middledoi
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
Radiotherapy and Oncology 2023cited by 15position: middledoi
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
Nature Genetics 2023cited by 0position: middledoi
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
Genome Medicine 2022cited by 54position: middledoi
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations
Cancer Epidemiology Biomarkers & Prevention 2022cited by 32position: middledoi
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry
Cancers 2022cited by 5position: middledoi
Exome sequencing identifies novel susceptibility genes and defines the contribution of coding variants to breast cancer risk
medRxiv 2022cited by 1position: middledoi
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
medRxiv 2021cited by 5position: middledoi
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention
Cancers 2020cited by 31position: middledoi
Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families
Journal of Clinical Oncology 2019cited by 409position: middledoi
Targeted Resequencing of the Coding Sequence of 38 Genes Near Breast Cancer GWAS Loci in a Large Case–Control Study
Cancer Epidemiology Biomarkers & Prevention 2019cited by 14position: middledoi
Prevalence of <i>BRCA1</i> and <i>BRCA2</i> pathogenic variants in a large, unselected breast cancer cohort
International Journal of Cancer 2018cited by 41position: middledoi
Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer
Cancer Research 2018cited by 25position: middledoi
Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer
Scientific Reports 2018cited by 7position: middledoi
Rare, protein-truncating variants in <i>ATM</i>, <i>CHEK2</i> and <i>PALB2</i>, but not <i>XRCC2</i>, are associated with increased breast cancer risks
Journal of Medical Genetics 2017cited by 93position: middledoi
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
Journal of Medical Genetics 2017cited by 51position: middledoi
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
Cancer Epidemiology Biomarkers & Prevention 2016cited by 393position: middledoi
No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testing
Journal of Medical Genetics 2016cited by 103position: middledoi
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
PLoS ONE 2016cited by 12position: middledoi
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Nature Genetics 2013cited by 1,105position: middledoi
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Nature Genetics 2013cited by 549position: middledoi
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
The American Journal of Human Genetics 2013cited by 214position: middledoi
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression
Human Molecular Genetics 2013cited by 110position: middledoi
Genome-wide association analysis identifies three new breast cancer susceptibility loci
Nature Genetics 2012cited by 284position: middledoi
Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping
BMC Medical Genomics 2012cited by 160position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alison M. Dunning · McMaster University5 papers (2012–2019)Douglas F. Easton · Pacific Biomarkers (United States)4 papers (2017–2019)Brennan Decker · University of Naples Federico II4 papers (2017–2019)Karen A. Pooley · University of Padua4 papers (2017–2019)Jamie Allen · European Bioinformatics Institute4 papers (2017–2019)Don Conroy · University of Cambridge3 papers (2017–2019)Paul D.P. Pharoah · University of Thessaly3 papers (2012–2019)Per Hall · Karolinska Institutet2 papers (2018–2018)Jacques Simard · McGill University Health Centre2 papers (2018–2018)Robert Luben · Moorfields Eye Hospital NHS Foundation Trust2 papers (2017–2019)Mitul Shah · University of Cambridge2 papers (2017–2019)Leila Dorling · Cancer Research UK Cambridge Center2 papers (2018–2018)Qin Wang · Jiangnan University2 papers (2017–2019)Judith Brown · University of Nebraska–Lincoln2 papers (2017–2019) · 2 papers (2018–2018)Manjeet K. Bolla · University of Cambridge2 papers (2017–2019) · 2 papers (2018–2018)Wei Wen · Chengdu Tool Research Institute (China)2 papers (2018–2018)Jingmei Li · Agency for Science, Technology and Research2 papers (2018–2018)Shahana Ahmed · University of Copenhagen2 papers (2017–2019)